Slade MJ - Search Results

1

Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.

Slade MJ, Singh A, Smith BM, Tripuraneni G, Hall E, Peckitt C, Fox S, Graham H, Lüchtenborg M, Sinnett HD, Cross NC, Coombes RC. Slade MJ, et al. Int J Cancer. 2005 Mar 10;114(1):94-100. doi: 10.1002/ijc.20655. Int J Cancer. 2005. PMID: 15523696

2

Reporter gene assay demonstrates functional differences in estrogen receptor activity in purified breast cancer cells: a pilot study.

Singh A, Ali S, Kothari MS, De Bella MT, Smith C, Timms E, Slade MJ, Foxwell BM, Coombes RC. Singh A, et al. Among authors: slade mj. Int J Cancer. 2003 Dec 10;107(5):700-6. doi: 10.1002/ijc.11469. Int J Cancer. 2003. PMID: 14566818

3

Expression of RPIP9 (Rap2 interacting protein 9) is activated in breast carcinoma and correlates with a poor prognosis.

Raguz S, De Bella MT, Slade MJ, Higgins CF, Coombes RC, Yagüe E. Raguz S, et al. Among authors: slade mj. Int J Cancer. 2005 Dec 20;117(6):934-41. doi: 10.1002/ijc.21252. Int J Cancer. 2005. PMID: 15986426

4

The clinical significance of disseminated tumor cells in breast cancer.

Slade MJ, Coombes RC. Slade MJ, et al. Nat Clin Pract Oncol. 2007 Jan;4(1):30-41. doi: 10.1038/ncponc0685. Nat Clin Pract Oncol. 2007. PMID: 17183354 Review.

5

Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.

Slade MJ, Smith BM, Sinnett HD, Cross NC, Coombes RC. Slade MJ, et al. J Clin Oncol. 1999 Mar;17(3):870-9. doi: 10.1200/JCO.1999.17.3.870. J Clin Oncol. 1999. PMID: 10071278

6

Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques.

Smith BM, Slade MJ, English J, Graham H, Lüchtenborg M, Sinnett HD, Cross NC, Coombes RC. Smith BM, et al. Among authors: slade mj. J Clin Oncol. 2000 Apr;18(7):1432-9. doi: 10.1200/JCO.2000.18.7.1432. J Clin Oncol. 2000. PMID: 10735890 Clinical Trial.

7

Microsatellite alterations plasma DNA of primary breast cancer patients.

Shaw JA, Smith BM, Walsh T, Johnson S, Primrose L, Slade MJ, Walker RA, Coombes RC. Shaw JA, et al. Among authors: slade mj. Clin Cancer Res. 2000 Mar;6(3):1119-24. Clin Cancer Res. 2000. PMID: 10741742

8

Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment.

Slade MJ, Payne R, Riethdorf S, Ward B, Zaidi SA, Stebbing J, Palmieri C, Sinnett HD, Kulinskaya E, Pitfield T, McCormack RT, Pantel K, Coombes RC. Slade MJ, et al. Br J Cancer. 2009 Jan 13;100(1):160-6. doi: 10.1038/sj.bjc.6604773. Epub 2008 Nov 25. Br J Cancer. 2009. PMID: 19034279 Free PMC article.

9

The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.

Payne RE, Hava NL, Page K, Blighe K, Ward B, Slade M, Brown J, Guttery DS, Zaidi SA, Stebbing J, Jacob J, Yagüe E, Shaw JA, Coombes RC. Payne RE, et al. Br J Cancer. 2012 Jan 17;106(2):375-82. doi: 10.1038/bjc.2011.537. Epub 2011 Dec 13. Br J Cancer. 2012. PMID: 22166803 Free PMC article.

10

Activation of the MDR1 upstream promoter in breast carcinoma as a surrogate for metastatic invasion.

Raguz S, Tamburo De Bella M, Tripuraneni G, Slade MJ, Higgins CF, Coombes RC, Yagüe E. Raguz S, et al. Among authors: slade mj. Clin Cancer Res. 2004 Apr 15;10(8):2776-83. doi: 10.1158/1078-0432.ccr-03-0517. Clin Cancer Res. 2004. PMID: 15102684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters